icon-    folder.gif   Conference Reports for NATAP  
 
  20th Conference on Retroviruses and
Opportunistic Infections
Atlanta, GA March 3 - 6, 2013
Back grey_arrow_rt.gif
 
 
 
Safety and Antiviral Activity of MK-1439, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), In Treatment-Naïve HIV-Infected Patients
 
 
  Reported by Jules Levin
CROI Atlanta March 3-6 2013
 
Matt S. Anderson1, Jocelyn Gilmartin1, Martine Robberechts2, Inge De Lepeleire2, Ernestina Tetteh1, Ying Guo1, Dirk Schurmann3, Frank Wagner4, John A. Wagner1, Joan R. Butterton1
1Merck Sharp & Dohme Corp., Whitehouse Station, NJ USA
2MSD Belgium, Brussels, Belgium
3Charite - Universitatsmedizin Berlin, Berlin, Germany
4Charite - Research Organisation, Berlin, Germany

CROI1.gif

CROI2.gif

CROI3.gif

CROI4.gif

CROI5.gif

CROI6.gif

CROI7.gif